EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer.
about
The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation.Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.Loss of cyclin-dependent kinase-like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion.Ubiquitin-specific protease 3 overexpression promotes gastric carcinogenesis and is predictive of poor patient prognosis
P2860
EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EPAC1 overexpression is a prog ...... potential for gastric cancer.
@en
EPAC1 overexpression is a prog ...... potential for gastric cancer.
@nl
type
label
EPAC1 overexpression is a prog ...... potential for gastric cancer.
@en
EPAC1 overexpression is a prog ...... potential for gastric cancer.
@nl
prefLabel
EPAC1 overexpression is a prog ...... potential for gastric cancer.
@en
EPAC1 overexpression is a prog ...... potential for gastric cancer.
@nl
P2093
P2860
P356
P1433
P1476
EPAC1 overexpression is a prog ...... potential for gastric cancer.
@en
P2093
Chia-Lang Fang
Ding-Ping Sun
Han-Kun Chen
Kai-Yuan Lin
Kuo-Shan Wen
Shih-Ting Hung
Yih-Huei Uen
You-Cheng Hseu
P2860
P304
P356
10.3892/OR.2017.5442
P577
2017-02-14T00:00:00Z